Avraham Raz
7Patents
4h-index
6Co-inventors
46Inventor score
Filing activity: Jul 14, 1992 → Dec 11, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5834442A | Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin | Human Necessities | 40 | Expired |
| US5895784A | Method for treatment of cancer by oral administration of modified pectin | Human Necessities | 31 | Expired |
| US5382521A | Method of determining metastatic potential of bladder tumor cells | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5650500A | Method of determining metastatic potential of bladder tumor cells | Emerging Cross-Sectional Technologies | 12 | Expired |
| US8349579B2 | Galectin-3 cleavage as a marker for matrix metalloproteinase activity in cancer | Physics | 3 | Active |
| US5801002A | Galactoside-binding-protein useful in the diagnosis and inhibition of of metastasis | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5541298A | Method of determining metastatic potential of tumor cells | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.